AVITA Medical to Host Acute Wound Care Showcase on May 13, 2025

Rhea-AI Summary

AVITA Medical (NASDAQ: RCEL) has announced its inaugural Acute Wound Care Showcase 2025, scheduled for May 13, 2025, at 11:00 a.m. Pacific Time via webcast. The event will feature presentations from CEO Jim Corbett and Dr. Katie Bush, Senior Vice President of Scientific and Medical Affairs.

The showcase will highlight AVITA Medical's comprehensive approach to acute wound care, featuring their product portfolio including RECELL®, Cohealyx™, and PermeaDerm®. Attendees will gain insights through physician testimonials and, for the first time, hear directly from patients whose lives have been transformed by these technologies.

The event will demonstrate the clinical and economic benefits of AVITA's technologies and conclude with a live Q&A session. Interested parties can register through the Events & Presentations section of AVITA Medical's Investor Relations website, with a replay available the following day.

VALENCIA, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced that it will host its inaugural Acute Wound Care Showcase 2025 on Tuesday, May 13, 2025, via webcast at 11:00 a.m. Pacific Time.

The event will feature presentations from Jim Corbett, Chief Executive Officer, and Dr. Katie Bush, Senior Vice President of Scientific and Medical Affairs. The Acute Wound Care Showcase will provide an overview of AVITA Medical’s comprehensive approach to acute wound care. Attendees joining the webcast will gain insights into the company’s product portfolio, including RECELL^®, Cohealyx^™, and PermeaDerm^®, as well as hear testimonials from physicians and patients.

“The Showcase is an opportunity to highlight how our product portfolio is reimagining acute wound care,” said Jim Corbett, Chief Executive Officer of AVITA Medical. “We will share compelling data and physician experiences that demonstrate the clinical and economic benefits of our technologies. For the first time, attendees will also hear directly from patients whose lives have been transformed by RECELL and our other products.”

The event will conclude with a live Q&A session. All interested parties may register and access the webcast via the Events & Presentations section of AVITA Medical’s Investor Relations site at ir.avitamedical.com. A replay will be available the following day.

About AVITA Medical, Inc.
AVITA Medical^® is a leading therapeutic acute wound care company delivering transformative solutions. Our technologies are designed to optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of our platform is the RECELL^® System, approved by the FDA for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin™ Cells, offering an innovative solution for improved clinical outcomes at the point-of-care. In the U.S., AVITA Medical also holds the exclusive rights to market, sell, and distribute both Cohealyx^™, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm^®, a biosynthetic wound matrix.

In international markets, the RECELL System is approved to promote skin healing in a wide range of applications including burns and full-thickness skin defects. The RECELL System, excluding RECELL GO^®, is TGA-registered in Australia, has received CE mark approval in Europe, and has PMDA approval in Japan.

To learn more, visit www.avitamedical.com.

Authorized for release by the Chief Financial Officer of AVITA Medical, Inc.

Investor & Media Contact:
Jessica Ekeberg
Phone +1-661-904-9269
investor@avitamedical.com
media@avitamedical.com

FAQ

When is AVITA Medical's Acute Wound Care Showcase 2025 and how can investors attend?

The showcase will be held on May 13, 2025, at 11:00 a.m. Pacific Time via webcast. Investors can register through AVITA Medical's Investor Relations website at ir.avitamedical.com.

What products will be featured in RCEL's Acute Wound Care Showcase?

The showcase will feature AVITA Medical's product portfolio, including RECELL®, Cohealyx™, and PermeaDerm® technologies for acute wound care.

Who are the key speakers at AVITA Medical's 2025 Showcase?

The event will feature presentations from Jim Corbett, Chief Executive Officer, and Dr. Katie Bush, Senior Vice President of Scientific and Medical Affairs.

Will there be patient testimonials at RCEL's 2025 Acute Wound Care Showcase?

Yes, for the first time, the showcase will include direct patient testimonials alongside physician experiences, demonstrating how AVITA Medical's products have transformed patients' lives.

How can investors access the replay of AVITA Medical's 2025 Showcase?

A replay of the showcase will be available the day following the event through the Events & Presentations section of AVITA Medical's Investor Relations website.